Changting Xiao
University of Saskatchewan(CA)
Publications by Year
Research Areas
Diabetes Treatment and Management, Pancreatic function and diabetes, Diet and metabolism studies, Diabetes, Cardiovascular Risks, and Lipoproteins, Diet, Metabolism, and Disease
Most-Cited Works
- → Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol(2016)209 cited
- → Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies(2010)192 cited
- → Sodium Phenylbutyrate, a Drug With Known Capacity to Reduce Endoplasmic Reticulum Stress, Partially Alleviates Lipid-Induced Insulin Resistance and β-Cell Dysfunction in Humans(2011)191 cited
- → New Insights into the Regulation of Chylomicron Production(2015)183 cited
- → Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans(2012)155 cited
- → Hypertriglyceridemia in the Genomic Era: A New Paradigm(2015)150 cited
- → Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans(2006)137 cited
- → Gut-liver interaction in triglyceride-rich lipoprotein metabolism(2011)124 cited
- → Both Intestinal and Hepatic Lipoprotein Production Are Stimulated by an Acute Elevation of Plasma Free Fatty Acids in Humans(2008)112 cited
- → Intranasal Insulin Suppresses Endogenous Glucose Production in Humans Compared With Placebo in the Presence of Similar Venous Insulin Concentrations(2014)107 cited